Sort by
Medicine and Dentistry
Pediatrics
100%
Heart Graft
89%
Rheumatic Heart Disease
83%
Apoplexy
83%
Atrial Fibrillation
83%
Antithrombotic
83%
Graft Failure
83%
Targeted Therapy
83%
Desensitization
83%
Rheumatic Fever
52%
Warfarin
50%
HLA Antibody
41%
Heart Transplantation
33%
Belatacept
27%
Carfilzomib
27%
Disease Severity
20%
Hazard Ratio
17%
Rebound
16%
Clinical Trial
16%
Coronary Artery Disease
16%
Apixaban
16%
Health Care Cost
16%
Antiplatelet Drug
16%
Rivaroxaban
16%
Off-Label Use
16%
Dabigatran
16%
Graft Survival
13%
Antibody Mediated Rejection
13%
Clinical Endpoint
13%
Human Immunodeficiency Virus
13%
Epstein Barr Virus
13%
Sensitization
13%
Antibody Response
13%
Proteasome Inhibitor
13%
Hematologic Malignancy
13%
Observational Study
13%
Exclusion Criterion
13%
Cardiac Allograft Vasculopathy
11%
Heart Muscle Ischemia
11%
Disease Burden
10%
Electronic Patient Record
10%
Benzathine Benzylpenicillin
10%
Nosology
10%
Patient Characteristics
10%
Odds Ratio
10%
Diseases
10%
Antimicrobial Agent
10%
Extracorporeal Membrane Oxygenation
5%
Cardiac Muscle Cell
5%
Ischemia
5%
Keyphrases
Atrial Fibrillation
83%
Stroke Prevention
83%
Novel Oral Anticoagulants
83%
United States
83%
Rheumatic Heart Disease
83%
Primary Graft Dysfunction
83%
Lasting Impact
83%
Rheumatic Fever
52%
Warfarin
50%
Medical Community
33%
Secondary Prophylaxis
20%
Disease Severity
20%
Central IRBs
20%
Hazard Ratio
19%
Rivaroxaban
16%
Dabigatran
16%
Safety Efficacy
16%
Bleeding Risk
16%
Renal Impairment
16%
Comparative Efficacy
16%
Clinical Experience
16%
Coronary Disease
16%
Clinical Trials
16%
Controversial Issues
16%
Apixaban
16%
Antiplatelet Drugs
16%
Off-label Use
16%
Data Experience
16%
Early Mortality
12%
Coronary Allograft Vasculopathy
12%
Ischemic Time
12%
Conditional Survival
12%
Electronic Medical Records
10%
Deprivation Index
10%
Deprivation
10%
Heart Disease Classification
10%
Community Deprivation
10%
Echocardiographic
10%
Descriptive Statistics
10%
Deprived Communities
10%
Endemic Region
10%
Socioeconomic Deprivation
10%
Benzathine Penicillin
10%
Age at Diagnosis
10%
Severe Disease
10%
Living with
10%
Initial Antibiotics
10%
Non-white
10%
Patient Characteristics
10%
Regression Analysis
10%
